These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38910518)

  • 1. Recent advances in N-glycan biomarker discovery among human diseases.
    Wang Y; Liu Y; Liu S; Cheng L; Liu X
    Acta Biochim Biophys Sin (Shanghai); 2024 Jun; ():. PubMed ID: 38910518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative O-glycomics based on improvement of the one-pot method for nonreductive O-glycan release and simultaneous stable isotope labeling with 1-(d
    Wang C; Zhang P; Jin W; Li L; Qiang S; Zhang Y; Huang L; Wang Z
    J Proteomics; 2017 Jan; 150():18-30. PubMed ID: 27585995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sweet systems: technologies for glycomic analysis and their integration into systems biology.
    Chen S; Qin R; Mahal LK
    Crit Rev Biochem Mol Biol; 2021 Jun; 56(3):301-320. PubMed ID: 33820453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical application of quantitative glycomics.
    Peng W; Zhao J; Dong X; Banazadeh A; Huang Y; Hussien A; Mechref Y
    Expert Rev Proteomics; 2018 Dec; 15(12):1007-1031. PubMed ID: 30380947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum N-glycomic profiling may provide potential signatures for surveillance of COVID-19.
    Xie Y; Butler M
    Glycobiology; 2022 Sep; 32(10):871-885. PubMed ID: 35925863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycomics and glycoproteomics focused on aging and age-related diseases--Glycans as a potential biomarker for physiological alterations.
    Miura Y; Endo T
    Biochim Biophys Acta; 2016 Aug; 1860(8):1608-14. PubMed ID: 26801879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isomer-specific profiling of N-glycans derived from human serum for potential biomarker discovery in pancreatic cancer.
    Liu Y; Wang C; Wang R; Wu Y; Zhang L; Liu BF; Cheng L; Liu X
    J Proteomics; 2018 Jun; 181():160-169. PubMed ID: 29674015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of the serum glycan state to predict ovarian cancer patients' clinical response to chemotherapy treatment.
    Zhao R; Lin G; Wang Y; Qin W; Gao T; Han J; Qin R; Pan Y; Sun J; Ren C; Ren S; Xu C
    J Proteomics; 2020 Jul; 223():103752. PubMed ID: 32209427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered glycosylation in cancer: A promising target for biomarkers and therapeutics.
    Thomas D; Rathinavel AK; Radhakrishnan P
    Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188464. PubMed ID: 33157161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and application of GlycanDIA workflow for glycomic analysis.
    Xie Y; Liu X; Zhao C; Chen S; Wang S; Lin Z; Robison FM; George BM; Flynn RA; Lebrilla CB; Garcia BA
    bioRxiv; 2024 Mar; ():. PubMed ID: 38559279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical approaches to perturb, profile, and perceive glycans.
    Agard NJ; Bertozzi CR
    Acc Chem Res; 2009 Jun; 42(6):788-97. PubMed ID: 19361192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Technologies and strategies for glycoproteomics and glycomics and their application to clinical biomarker research.
    Tousi F; Hancock WS; Hincapie M
    Anal Methods; 2011 Jan; 3(1):20-32. PubMed ID: 32938106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MS-based glycomics: An analytical tool to assess nervous system diseases.
    Peng W; Kobeissy F; Mondello S; Barsa C; Mechref Y
    Front Neurosci; 2022; 16():1000179. PubMed ID: 36408389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantifying Protein-Specific N-Glycome Profiles by Focused Protein and Immunoprecipitation Glycomics.
    Kobayashi T; Ogawa K; Furukawa JI; Hanamatsu H; Hato M; Yoshinaga T; Morikawa K; Suda G; Sho T; Nakai M; Higashino K; Numata Y; Shinohara Y; Sakamoto N
    J Proteome Res; 2019 Aug; 18(8):3133-3141. PubMed ID: 31266306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycomic analysis by glycoprotein immobilization for glycan extraction and liquid chromatography on microfluidic chip.
    Yang S; Toghi Eshghi S; Chiu H; DeVoe DL; Zhang H
    Anal Chem; 2013 Nov; 85(21):10117-25. PubMed ID: 24111616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoglobulin G N-glycan Biomarkers for Autoimmune Diseases: Current State and a Glycoinformatics Perspective.
    Flevaris K; Kontoravdi C
    Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human disease glycomics: technology advances enabling protein glycosylation analysis - part 1.
    Everest-Dass AV; Moh ESX; Ashwood C; Shathili AMM; Packer NH
    Expert Rev Proteomics; 2018 Feb; 15(2):165-182. PubMed ID: 29285957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-throughput and high-sensitivity N-Glycan profiling: A platform for biopharmaceutical development and disease biomarker discovery.
    Xie Y; Mota LM; Bergin A; O'Flaherty R; Jones A; Morgan B; Butler M
    Anal Biochem; 2021 Jun; 623():114205. PubMed ID: 33891963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mass spectrometric profiling reveals association of N-glycan patterns with epithelial ovarian cancer progression.
    Chen H; Deng Z; Huang C; Wu H; Zhao X; Li Y
    Tumour Biol; 2017 Jul; 39(7):1010428317716249. PubMed ID: 28681696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-glycomic profiling of colorectal cancer according to tumor stage and location.
    Holm M; Nummela P; Heiskanen A; Satomaa T; Kaprio T; Mustonen H; Ristimäki A; Haglund C
    PLoS One; 2020; 15(6):e0234989. PubMed ID: 32598367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.